At the time of writing, Trevi Therapeutics Inc [TRVI] stock is trading at $3.51, up 4.15%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TRVI shares have gain 12.50% over the last week, with a monthly amount glided 27.64%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Raymond James started tracking the stock with Outperform rating on August 30, 2024, and set its price target to $9. On August 30, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $6 on the stock. Rodman & Renshaw started tracking the stock assigning a Buy rating and suggested a price target of $7 on June 13, 2024. B. Riley Securities initiated its recommendation with a Buy and recommended $6 as its price target on April 12, 2023. SVB Leerink started tracking with a Outperform rating for this stock on November 22, 2022, and assigned it a price target of $6. In a note dated June 03, 2019, SVB Leerink initiated an Outperform rating and provided a target price of $14 on this stock.
For the past year, the stock price of Trevi Therapeutics Inc fluctuated between $0.97 and $4.00. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Trevi Therapeutics Inc [NASDAQ: TRVI] shares were valued at $3.51 at the most recent close of the market. An investor can expect a potential return of 241.88% based on the average TRVI price forecast.
Analyzing the TRVI fundamentals
Gross Profit Margin for this corporation currently stands at 0.19% with Operating Profit Margin at -245.3%, Pretax Profit Margin comes in at -220.36%, and Net Profit Margin reading is -220.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.5 and Total Capital is -0.64. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.37 points at the first support level, and at 3.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.67, and for the 2nd resistance point, it is at 3.82.
Ratios To Look Out For
It is important to note that Trevi Therapeutics Inc [NASDAQ:TRVI] has a current ratio of 10.68. Further, the Quick Ratio stands at 10.68, while the Cash Ratio is 1.92.
Transactions by insiders
Recent insider trading involved GOOD JENNIFER L, President & CEO, that happened on Sep 06 ’24 when 4219.0 shares were sold. President & CEO, GOOD JENNIFER L completed a deal on Sep 09 ’24 to sell 1840.0 shares. Meanwhile, President & CEO GOOD JENNIFER L sold 40277.0 shares on Sep 05 ’24.
